Full name
FARMAZONA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
73.11.Z - Advertising agency activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,3 | 0,5 | -0 | -101,3 |
EBITDA | 1,6 | 0,7 | 0,2 | -77,6 |
Short time liabilities | 5,1 | 7,7 | 10,8 | 39,3 |
Equity capital | -1,9 | -1,4 | -1,4 | -0,4 |
Operating profit (EBIT) | 1,5 | 0,6 | 0,1 | -82,8 |
Assets | 7,9 | 10,2 | 12,2 | 19,8 |
Net profit (loss) | 1,3 | 0,5 | -0 | -101,3 |
Cash | 0,7 | 0,8 | 1 | 20,5 |
Net income from sale | 52,9 | 64,8 | 80,8 | 24,7 |
Liabilities and provisions for liabilities | 9,8 | 11,6 | 13,6 | 17,4 |
Working assets | 7,8 | 10 | 11,9 | 19,2 |
Depreciation | 0,1 | 0,1 | 0,1 | -50,1 |
% | % | % | p.p. | |
Profitability of capital | -71,5 | -33,1 | 0,4 | 33,5 |
Equity capital to total assets | -23,9 | -13,9 | -11,7 | 2,2 |
Gross profit margin | 2,5 | 0,7 | -0 | -0,7 |
EBITDA Margin | 2,9 | 1,1 | 0,2 | -0,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 35 | 44 | 49 | 5 |
Current financial liquidity indicator | 1.337673544883728 | 1.180355191230774 | 1.0257192850112915 | -0,2 |
Net dept to EBITDA | 2.0481948852539062 | 3.204127788543701 | 9.092694282531738 | 5,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane